Mometasone
- Generic Name
- Mometasone
- Brand Names
- Asmanex, Dulera, Elocom, Elocon, Nasonex, Ryaltris, Sinuva, Zenhale
- Drug Type
- Small Molecule
- Chemical Formula
- C27H30Cl2O6
- CAS Number
- 83919-23-7
- Unique Ingredient Identifier
- 04201GDN4R
- Background
Mometasone furoate is a corticosteroid drug that can be used for the treatment of asthma, rhinitis, and certain skin conditions. It has a glucocorticoid receptor binding affinity 22 times stronger than dexamethasone and higher than many other corticosteroids as well. Mometasone furoate is formulated as a dry powder inhaler, nasal spray, and ointment for its ...
- Indication
Inhaled mometasone furoate is indicated for prophylaxis of asthma in patients ≥4 years. Applied topically as an ointment, mometasone furoate is indicated for symptomatic treatment of dermatitis and pruritis in patients ≥2 years.
...
- Associated Conditions
- Asthma, Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP), Dermatitis, Dermatitis, Eczematous caused by superficial Fungal skin infection, Moderate to Severe Plaque Psoriasis, Pruritus, Psoriasis, Psoriasis, Moderate to Severe, Seasonal Allergic Rhinitis, Seasonal Allergies, Skin Diseases, Eczematous, Skin Infections, Moderate, severe Seasonal Allergic Rhinitis, Ocular effects
- Associated Therapies
- -
Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata
- Conditions
- First Posted Date
- 2024-05-06
- Last Posted Date
- 2024-05-06
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 54
- Registration Number
- NCT06399783
- Locations
- 🇪🇬
Assiut university, Assiut, Egypt
Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis
- Conditions
- Interventions
- First Posted Date
- 2023-06-05
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 38
- Registration Number
- NCT05887843
- Locations
- 🇨🇦
Sandoz Investigational Site, Toronto, Ontario, Canada
Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis
- Conditions
- Interventions
- First Posted Date
- 2022-04-05
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 669
- Registration Number
- NCT05311475
- Locations
- 🇵🇱
Sandoz Investigative Site, Wrocław, Poland
Research on Underlying Causes of Long-term Use of Nasal Decongestants and the Structured Withdrawal of the Decongestant
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 135
- Registration Number
- NCT04898764
- Locations
- 🇧🇪
Ghent University Hospital, Ghent, Belgium
Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis
- Conditions
- Interventions
Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.
- Conditions
- Interventions
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- Seanergy Dermatology Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT04615962
Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma
- Conditions
- Interventions
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 24
- Registration Number
- NCT04589663
- Locations
- 🇿🇦
Novartis Investigative Site, Cape Town, South Africa
Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis
- Conditions
- Interventions
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2020-08-31
- Lead Sponsor
- Dokuz Eylul University
- Target Recruit Count
- 41
- Registration Number
- NCT04532736
- Locations
- 🇹🇷
Dokuz Eylul University School of Medicine, İzmir, General, Turkey
A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid
- Conditions
- Interventions
- First Posted Date
- 2020-08-05
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Alkahest, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT04499235
- Locations
- 🇩🇪
Universitätsklinikum Freiburg Klinik für Dermatologie und Venerologie, Freiburg, Germany
🇩🇪Universitätsklinikum Carl Gustav Carus Dresden Klinik und Poliklinik für Dermatologie, Dresden, Germany
🇩🇪Universitätsmedizin der Johannes Gutenberg-Universität Mainz Hautklinik Clinical Research Center (CRC), Mainz, Germany
Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoates
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- Libbs Farmacêutica LTDA
- Target Recruit Count
- 32
- Registration Number
- NCT04271007
- Locations
- 🇧🇷
Dr Sérgio Sckalka, Osasco, São Paulo, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.